SapVax is advancing discoveries made by researchers from the University of Auckland in New Zealand. Their academic founders have developed a novel chemistry platform for coupling immunogenic peptides to TLR2-agonist adjuvants to generate fully-synthetic, self-adjuvanting cancer vaccines. The Sapvax... Read more
This company has no teams yet
Solace
2 followers
Merck
351 followers
Allyx Therapeutics
2 followers
Healthcare Shares
1 follower
Methodist Health System
2 followers
Johnson & Johnson
682 followers
Biolinq
2 followers
Yamo Pharmaceuticals
1 follower
Thermo Fisher Scientific
289 followers
Genentech
228 followers
Gilead Sciences
218 followers
Regeneron
187 followers